Literature DB >> 22014839

Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography.

Yau-Huei Lai1, Chun-Ho Yun, Fei-Shih Yang, Chuan-Chuan Liu, Yih-Jer Wu, Jen-Yuan Kuo, Hung-I Yeh, Tin-Yu Lin, Hiram G Bezerra, Shou-Chuan Shih, Cheng-Ho Tsai, Chung-Lieh Hung.   

Abstract

BACKGROUND: Epicardial adipose tissue (EAT) measured by echocardiography has been proposed to be associated with metabolic syndrome and increased cardiovascular risks. However, its independent association with fatty liver disease and systemic inflammation beyond clinical variables and body fat remains less well known.
METHODS: The relationships between EAT and various factors of metabolic derangement were retrospectively examined in consecutive 359 asymptomatic subjects (mean age, 51.6 years; 31% women) who participated in a cardiovascular health survey. Echocardiography-derived regional EAT thickness from parasternal long-axis and short-axis views was quantified. A subset of data from 178 randomly chosen participants were validated using 16-slice multidetector computed tomography. Body fat composition was evaluated using bioelectrical impedance from foot-to-foot measurements.
RESULTS: Increased EAT was associated with increased waist circumference, body weight, and body mass index (all P values for trend = .005). Graded increases in serum fasting glucose, insulin resistance, and alanine transaminase levels were observed across higher EAT tertiles as well as a graded decrease of high-density lipoprotein (all P values for trend <.05). The areas under the receiver operating characteristic curves for identifying metabolic syndrome and fatty liver disease were 0.8 and 0.77, with odds ratio estimated at 3.65 and 2.63, respectively. In a multivariate model, EAT remained independently associated with higher high-sensitivity C-reactive protein and fatty liver disease.
CONCLUSIONS: These data suggested that echocardiography-based epicardial fat measurement can be clinically feasible and was related to several metabolic abnormalities and independently associated fatty liver disease. In addition, EAT amount may contribute to systemic inflammation beyond traditional cardiovascular risks and body fat composition.
Copyright © 2012 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014839     DOI: 10.1016/j.echo.2011.09.018

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  22 in total

1.  Association of epicardial fat thickness with TIMI risk score.

Authors:  S Balta; U Canpolat
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

Review 2.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

3.  Epicardial fat thickness: distribution and association with diabetes mellitus, hypertension and the metabolic syndrome in the ELSA-Brasil study.

Authors:  Daniela Bertol Graeff; Murilo Foppa; Julio Cesar Gall Pires; Alvaro Vigo; Maria Ines Schmidt; Paulo Andrade Lotufo; Jose Geraldo Mill; Bruce Bartholow Duncan
Journal:  Int J Cardiovasc Imaging       Date:  2015-11-19       Impact factor: 2.357

4.  Epicardial Fat Thickness is Associated with Abnormal Left Ventricle Geometry in Newly Diagnosed Hypertension.

Authors:  Taner Şeker; Caner Türkoğlu; Hazar Harbalıoğlu; Mustafa Gür
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

5.  Correlation of epicardial fat and anthropometric measurements in Asian-Indians: A community based study.

Authors:  Ranjan Shetty; G Vivek; Kushal Naha; Krishnananda Nayak; Amit Goyal; Lorraine S Dias
Journal:  Avicenna J Med       Date:  2012-10

6.  The association among MDCT-derived three-dimensional visceral adiposities on cardiac diastology and dyssynchrony in asymptomatic population.

Authors:  Yau-Huei Lai; Charles Jia-Yin Hou; Chun-Ho Yun; Kuo-Tzu Sung; Cheng-Huang Su; Tung-Hsin Wu; Fei-Shih Yang; Ta-Chuan Hung; Chung-Lieh Hung; Hiram G Bezerra; Hung-I Yeh
Journal:  BMC Cardiovasc Disord       Date:  2015-10-30       Impact factor: 2.298

7.  Excessive interatrial adiposity is associated with left atrial remodeling, augmented contractile performance in asymptomatic population.

Authors:  Yau-Huei Lai; Chun-Ho Yun; Cheng-Huang Su; Fei-Shih Yang; Hung-I Yeh; Charles Jia-Yin Hou; Tung-Hsin Wu; Ricardo C Cury; Hiram G Bezerra; Chung-Lieh Hung
Journal:  Echo Res Pract       Date:  2016-01-05

8.  Epicardial adipose tissue thickness and ablation outcome of atrial fibrillation.

Authors:  Tze-Fan Chao; Chung-Lieh Hung; Hsuan-Ming Tsao; Yenn-Jiang Lin; Chun-Ho Yun; Yau-Huei Lai; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Hung-Yu Chang; Jen-Yuan Kuo; Hung-I Yeh; Tsu-Juey Wu; Ming-Hsiung Hsieh; Wen-Chung Yu; Shih-Ann Chen
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

Review 9.  Epicardial fat: definition, measurements and systematic review of main outcomes.

Authors:  Angela Gallina Bertaso; Daniela Bertol; Bruce Bartholow Duncan; Murilo Foppa
Journal:  Arq Bras Cardiol       Date:  2013-07       Impact factor: 2.000

10.  Epicardial adipose tissue should be evaluated with other inflammatory markers in patients with subclinical hypothyroidism.

Authors:  Sevket Balta; Sait Demırkol; Ugur Kucuk; Zekeriya Arslan; Murat Unlu; Fahri Gurkan Yesil
Journal:  Med Princ Pract       Date:  2013-04-06       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.